Page 104 - Read Online

Liu et al. Hepatoma Res 2020;6:42 I http://dx.doi.org/10.20517/2394-5079.2020.25 Page 9 of 12

Risk stratification, HCC surveillance and treatment, Figure 1: Liu K
Introduction, epidemiology of AC-HCC, risk prediction: Trepo E, Verset G
Introduction, genetic variants, genetic variants risk prediction: Seth D
All authors critically reviewed the manuscript.

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2020.

REFERENCES
1. Villanueva A. Hepatocellular carcinoma. Engl J Med 2019;380:1450-62.
2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and
mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424.
3. Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet 2018;391:1301-14.
4. Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and
management. Nat Rev Gastroenterol Hepatol 2019;16:589-604.
5. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology
2004;126:460-8.
6. N’Kontchou G, Paries J, Htar MTT, Ganne-Carrie N, Costentin L, et al. Risk factors for hepatocellular carcinoma in patients with
alcoholic or viral C cirrhosis. Clin Gastroenterol Hepatol 2006;4:1062-8.
7. Zaman SN, Melia WM, Johnson RD, Portmann BC, Johnson PJ, et al. Risk factors in development of hepatocellular carcinoma in
cirrhosis: prospective study of 613 patients. Lancet 1985;1:1357-60.
8. Yu MW, Chang HC, Liaw YF, Lin SM, Lee SD, et al. Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and
their relatives. J Natl Cancer Inst 2000;92:1159-64.
9. Hemminki K, Li X. Familial liver and gall bladder cancer: a nationwide epidemiological study from Sweden. Gut 2003;52:592-6.
10. Rich NE, Hester C, Odewole M, Murphy CC, Parikh ND, et al. Racial and ethnic differences in presentation and outcomes of
hepatocellular carcinoma. Clin Gastroenterol Hepatol 2019;17:551-9.e1.
11. Herbst DA, Reddy KR. Risk factors for hepatocellular carcinoma. Clin Liver Dis 2012;1:180-2.
12. Stickel F, Schuppan D, Hahn EG, Seitz HK. Cocarcinogenic effects of alcohol in hepatocarcinogenesis. Gut 2002;51:132-9.
13. Ganne-Carrié N, Chaffaut C, Bourcier V, Archambeaud I, Perarnau JM, et al. Estimate of hepatocellular carcinoma incidence in patients
with alcoholic cirrhosis. J Hepatol 2018;69:1274-83.
14. Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology 2004;127:S87-96.
15. Roerecke M, Vafaei A, Hasan OSM, Chrystoja BR, Cruz M, et al. Alcohol consumption and risk of liver cirrhosis: a systematic review
and meta-analysis. Am J Gastroenterol 2019;114:1574-86.
16. Grewal P, Viswanathen VA. Liver cancer and alcohol. Clin Liver Dis 2012;16:839-50.
17. Ganne-Carrié N, Nahon P. Hepatocellular carcinoma in the setting of alcohol-related liver disease. J Hepatol 2019;70:284-93.
18. Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, et al. The burden of primary liver cancer and underlying etiologies from
1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015. JAMA Oncol 2017;3:1683-
91.
19. Heckley GA, Jarl J, Asamoah BO, G-Gerdtham U. How the risk of liver cancer changes after alcohol cessation: a review and meta-